Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pressure Biosciences (OP: PBIO )

0.0060 UNCHANGED
Streaming Delayed Price Updated: 1:17 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Pressure Biosciences

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Pressure BioSciences Partnership with QVC Skincare Leader Dr. Denese SkinScience Yields Unprecedented Effectiveness in Skin Tightening and Wrinkle Reduction
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured on Stock Day Podcast
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences Securing and Fulfilling UltraShear Nanoemulsions Contracts, Discussed on "Stock Day Podcast"
Phoenix, Arizona--(Newsfile Corp. - December 5, 2022) - The Stock Day Podcast recently welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI"... 
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences, Inc. Reports Q3 2022 Financial Results and Offers Business Update on Ultra Shear Technology Nanoemulsions Commercialization Progress
Via ACCESSWIRE
Pressure BioSciences, Inc. to Discuss Third Quarter 2022 Financial Results and Provide Business Update
Via ACCESSWIRE
Pressure BioSciences, Inc. to Discuss Second Quarter 2022 Financial Results and Provide Business Update
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Discuss Q3 2022 Results, Provide Business Update
Via Investor Brand Network
7 Stocks to Sell Right Now… and 1 to Buy
Although red ink can sometimes bring an opportunity for contrarianism, these (except one) market ideas represent stocks to sell. 
Via InvestorPlace
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Dr. Denese SkinScience to Introduce UST Nanoemulsion Hair Regrowth Product in 2023
Via Investor Brand Network
Pressure BioSciences and Leading Cosmeceuticals Innovator Dr. Denese SkinScience to Introduce Revolutionary UST Nanoemulsion Hair Regrowth Product in 2023
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Participate in Emerging Growth Conference Presentation
Via Investor Brand Network
Pressure BioSciences and Leading Cosmeceuticals Company Dr. Denese SkinScience Present Their Partnership Progress in FORCE Family Office October 13th Webinar
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) to Focus on Launch of Proprietary UST Processing Method in Emerging Growth Conference Presentation
Via Investor Brand Network
Imminent Commercial Launch of Revolutionary UST Processing Method to be Focus of Pressure BioSciences Presentation at Emerging Growth Conference 40 on September 28, 2022
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Academia-Industry Partnership with The Ohio State University
Via Investor Brand Network
Unique Advantages and Commercial Process Scalability of Pressure BioSciences Revolutionary UST Platform Illuminated at the Conference of Food Engineering 2022
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Participation at H. C. Wainwright Annual Global Investment Conference
Via Investor Brand Network
Pressure BioSciences to Expand on Pivotal Change in Business Strategy with Presentation at H. C. Wainwright Annual Global Investment Conference on September 13th
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Partners with Skincare Leader, Icon and Pioneer
Via Investor Brand Network
Pressure Biosciences Secures Partnership With Dr. Denese SkinScience, A 20-Year Leader In Cosmeceuticals With Over $500 Million In Sales
Pressure BioSciences Inc. 
Via Benzinga
Global Cosmeceuticals Market Size Projected Reach $96 Billion By 2029 as Demand is Booming
Palm Beach, FL – August 24, 2022 – FinancialNewsMedia.com News Commentary – The demand for cosmeceutical products is growing globally due to the rising prevalence of skin and hair disorders, increasing... 
Via FinancialNewsMedia
Exposures COVID-19
Pressure BioSciences Secures Pivotal Cosmeceuticals Partnership for UST Platform with Dr. Denese SkinScience, 20-Year Leader with Over $0.5 Billion in QVC Sales
Collaborative UST-Driven Research and Development Agreement Announced with Dr. Adrienne Denese (QVC Icon, Skincare Visionary, Anti-Aging Pioneer, & Creator of Award-Winning SkinScience Labs) Targets... 
Via FinancialNewsMedia
Pressure BioSciences Secures Pivotal Cosmeceuticals Partnership for UST Platform With Dr. Denese SkinScience, 20-Year Leader With Over $0.5 Billion in QVC Sales
Via ACCESSWIRE
EXCLUSIVE: Pressure BioSciences Inks Cosmeceuticals Partnership Using Nano Emulsification Platform
Pressure BioSciences Inc (OTC: PBIO) has teamed up with Dr. Adrienne Denese for a two-year Collaborative Research and Development Agreement. 
Via Benzinga
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters Strategic Agreement with Canopy CBD Farms
Via Investor Brand Network
Pressure BioSciences Announces Contract for October 2022 Launch of Breakthrough Hemp-Derived CBD Product, Estimating $2 Million Incremental 2023 Revenue
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Approval to Manufacture Hemp-Derived CBD Products in South Easton Facility
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Announces Approval to Manufacture Hemp-Derived CBD Products in Massachusetts, Including Their Revolutionary CBD Nanoemulsions
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Gathers Leads at Events, Notes Rapid Market Expansion
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis
Pressure BioSciences Doubles Growth Projections for UST Nanoemulsion Contracts Following Clear Confirmation of Unmet Needs in Exploding Cannabis Drinks Sector
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.